Citi Downgrades Edwards Lifesciences (EW) to Neutral, 'Near term still transitional'

December 11, 2023 7:51 AM EST Send to a Friend
(Updated - December 11, 2023 7:53 AM EST)

Citi analyst Joanna Wuensch downgraded Edwards Lifesciences (NYSE: EW) from Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login